Literature DB >> 30686255

Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives.

Junfu Zhang1,2, Liying Wang3, Xinru You3, Tuzeng Xian2, Jun Wu3,4, Jun Pang1.   

Abstract

Traditional prostate cancer therapy and especially chemotherapy has faced many challenges. Low accumulation levels, rapid clearance or drug resistance at the tumor site have been central to why the effect of chemotherapy drugs has declined. Applications of nanotechnology to biomedicine have enabled the development of nanoparticle therapeutic carriers suited for the delivery of chemotherapeutics in cancer therapy. This review describes the current nature of nanoparticle therapeutic carriers for prostate cancer. It describes typical nanocarriers commonly used for the delivery of chemotherapy or for imaging examination. Targeting strategies and related influencing factors are investigated to find ways of enhancing treatment effects of nanoparticles. The overall purpose of this review is to further understanding and to offer recommendations on the design and development of therapeutic nanoparticles for prostate cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Chemotherapy; Drug delivery; ERP effect; Nanoparticles; Prostate cancer; Targeting strategies.

Mesh:

Substances:

Year:  2019        PMID: 30686255     DOI: 10.2174/1568026619666190125145836

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  7 in total

1.  Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines.

Authors:  Sandeep Vaidya; Manish Kumar Jeengar; Mohammad Ahmad Wadaan; Shahid Mahboob; Pankaj Kumar; Lisa M Reece; Surender Reddy Bathula; Mycal Dutta
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-06       Impact factor: 2.650

2.  Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.

Authors:  Wenfeng Lin; Chaoming Li; Naijin Xu; Masami Watanabe; Ruizhi Xue; Abai Xu; Motoo Araki; Ruifen Sun; Chunxiao Liu; Yasutomo Nasu; Peng Huang
Journal:  Int J Nanomedicine       Date:  2021-04-12

3.  Aptamer-Conjugated Multifunctional Polymeric Nanoparticles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems for Treatment of Castration-Resistant Prostate Cancer.

Authors:  Youqiang Fang; Shaoxiong Lin; Fei Yang; Jie Situ; Shudong Lin; Yun Luo
Journal:  Biomed Res Int       Date:  2020-04-25       Impact factor: 3.411

Review 4.  Nanomaterial Technology and Triple Negative Breast Cancer.

Authors:  Kai Hou; Zeng Ning; Hongbo Chen; Yiping Wu
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

Review 5.  A technical note on emerging combination approach involved in the onconanotherapeutics.

Authors:  Mohammad Kashif Iqubal; Harsimran Kaur; Shadab Md; Nabil A Alhakamy; Ashif Iqubal; Javed Ali; Sanjula Baboota
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 6.  Surface-functionalised hybrid nanoparticles for targeted treatment of cancer.

Authors:  Hasnat Tariq; Syed Ali Imran Bokhari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

7.  Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer.

Authors:  Qier Xia; Jun Li; Zhenyu Yang; Dingguo Zhang; Jinjun Tian; Bin Gu
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.